A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma by Hamid Omid, Schmidt Henrik, Nissan Aviram, Ridolfi Laura, Aamdal Steinar, Hansson Johan, Guida Michele, Hyams David M, Gómez Henry, Bastholt Lars, Chasalow Scott D, Berman David

Get full text